Project/Area Number |
05671394
|
Research Category |
Grant-in-Aid for General Scientific Research (C)
|
Allocation Type | Single-year Grants |
Research Field |
Obstetrics and gynecology
|
Research Institution | IWATE MEDICAL UNIVERSITY |
Principal Investigator |
IZUTSU Toshihiko IWATE MEDICAL UNIVERSITY.DEPARTMENT OF OBSTETRICS AND GYNECOLOGY.ASSOCIATE PROFFSSOR, 医学部, 助教授 (00103739)
|
Co-Investigator(Kenkyū-buntansha) |
FUKUSHIMA Akimune IWATE MEDICAL UNIVERSITY.DEPARTMENT OF OBSTETRICS AND GYNECOLOGY.RESIDENT, 医学部, 助手 (20208937)
SATO Masayuki IWATE MEDICAL UNIVERSITY.DEPARTMENT OF OBSTETRICS AND GYNECOLOGY.RESIDENT, 医学部, 助手 (20183387)
|
Project Period (FY) |
1992 – 1994
|
Project Status |
Completed (Fiscal Year 1994)
|
Budget Amount *help |
¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 1994: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1993: ¥1,300,000 (Direct Cost: ¥1,300,000)
|
Keywords | ENDOMETRIAL CANCER / CHROMOSOME / STEROID HORMONE / supressor gene / oncogene |
Research Abstract |
I) Chromosomal analysis of endometrial cancer cells treated with steroid hormon Endometrial cancer cell line (Ishikawa, HEC-1) were treated with 2x10^<-5>M Progesterone (P) and 2x10^<-5>M Danazol (D). Ishikawa (IK) cell was not decreased treated with p or D. HEC-1 (HEC) cell also was not decreased with P and D. No chromosomal abnormalities were observed treated with Por D in IK or HEC. II) chromosomal analysis of endometrial cancer cells treated with anticancer drug Endometrial cancer cell line (IK) were treated with 5mug/ml CDDP (C) or 1x10^<-5>M Taxol (T). Growth suppression (74%) was observed in IK cell after 24 hours exposure with C. Growth suppression (62%) was observed in IK cell after 24 hours exposure with T. HEC cell was not decreased after 4,8, or 24 hours exposure with C. Growth suuppression (57%) was observed in IK cell after 4 hours exposure with T. No chromosomal abnormalities were observed treated with T in IK or HEC. chromosomal abnormalities such as gap, ctb, cte and csb were observed treated with C in IK or HEC.
|